2,2',3,5',6-Pentachlorobiphenyl-13C12
Stock Status: Enquire
Live
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
CAT No. CS-T-102143
CAS No. --
Research Use
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
2,2',3,5',6-Pentachlorobiphenyl-13C12 Product Information
2,2',3,5',6-Pentachlorobiphenyl-13C12 is listed under Stable Isotopes. It is associated with - and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-102143.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
2,2',3,5',6-Pentachlorobiphenyl-13C12
CAS No.
-
CAT No.
CS-T-102143
Molecular Formula
¹³C12H5Cl5
Molecular Weight
338.34
Category
API Family
Storage Condition
Refer MSDS for complete information.
SMILES
Cl[13C]1=[13C]([13C]2=[13CH][13C](Cl)=[13CH][13CH]=[13C]2Cl)[13C](Cl)=[13C](Cl)[13CH]=[13CH]1
IUPAC Name
"2,2',3,5',6-Pentachlorobiphenyl-13C12"
Hazard Compound
Refer MSDS for complete information.
Description
Overview
"2,2',3,5',6-Pentachlorobiphenyl-13C12 is the labeled analogue of 2,2',3,5',6-Pentachlorobiphenyl (P237935), an environmental neurotoxicant that promotes synaptogenesis through ryanodine receptor-dependent miR132 upregulation."
Synonyms
"(±)-PCB 95-13C12; 2,2',3',5,6'-Pentachlorobiphenyl-13C12; 2,3,6,2',5'-Pentachlorobiphenyl-13C12; 2,5,2',3',6'-Pentachlorobiphenyl-13C12; PCB 95-13C12; 2,2',3,5',6-Pentachloro-1,1'-biphenyl-13C12"
Application Notes
"2,2',3,5',6-Pentachlorobiphenyl-13C12 is the labeled analogue of 2,2',3,5',6-Pentachlorobiphenyl (P237935), an environmental neurotoxicant that promotes synaptogenesis through ryanodine receptor-dependent miR132 upregulation."
References
"Lesiak, A., et. al.: J. Neurosci., 34, 717 (2014)"
